StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
450
This month
7
This week
2
This year
61
Yesterday
2
Publishing Date
2024 - 03 - 11
5
2024 - 01 - 24
3
2024 - 01 - 12
4
2023 - 12 - 12
3
2023 - 12 - 01
3
2023 - 08 - 25
3
2023 - 06 - 28
3
2023 - 04 - 13
4
2023 - 02 - 13
3
2023 - 02 - 02
3
2022 - 12 - 15
2
2022 - 12 - 06
5
2022 - 11 - 28
3
2022 - 11 - 10
2
2022 - 11 - 08
2
2022 - 11 - 03
2
2022 - 11 - 02
2
2022 - 10 - 19
2
2022 - 10 - 14
2
2022 - 10 - 06
2
2022 - 09 - 28
2
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 09 - 16
2
2022 - 09 - 13
2
2022 - 08 - 22
2
2022 - 08 - 08
2
2022 - 08 - 05
2
2022 - 08 - 02
3
2022 - 07 - 26
2
2022 - 07 - 19
2
2022 - 07 - 13
2
2022 - 06 - 27
3
2022 - 06 - 24
2
2022 - 06 - 17
3
2022 - 06 - 03
3
2022 - 05 - 25
2
2022 - 05 - 23
2
2022 - 05 - 17
3
2022 - 05 - 16
4
2022 - 04 - 26
3
2022 - 04 - 21
2
2022 - 03 - 28
2
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 09
2
2022 - 03 - 03
3
2022 - 03 - 02
2
2022 - 03 - 01
3
2022 - 02 - 23
2
2022 - 02 - 22
2
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2022 - 01 - 21
2
2021 - 11 - 24
3
2021 - 11 - 03
2
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 04
2
Sector
Commercial services
4
Communications
4
Consumer non-durables
7
Consumer services
2
Distribution services
2
Electronic technology
5
Finance
4
Health services
7
Health technology
450
Information
2
Manufacturing
65
Mining, quarrying, and oil and gas extraction
2
N/a
32
Non-energy minerals
1
Process industries
9
Producer manufacturing
11
Professional, scientific, and technical services
12
Retail trade
2
Technology services
7
Tags
Abbvie
5
America
27
Antibody
6
Approval
5
Art27
5
Art27.13
5
Astrazeneca
9
Biotech
27
Business
7
Cancer
74
Cell
9
Companies
5
Covid-19
5
Diabetes
10
Disease
23
Drug
48
Drug delivery
10
Earnings
6
Events
5
Expansion
5
Expected
12
Fda
5
Financial
10
Global
104
Growing
22
Growth
107
Health
7
Immunotherapy
8
Influenza
5
Iot
6
Key
9
Liver
15
Lung
11
Lung cancer
5
Management
5
Market
263
N/a
400
People
9
Pharma
5
Positive
5
Protein
5
Reach
20
Report
95
Reqorsa
5
Research
50
Respiratory
7
Results
20
Review
6
Sanofi
6
Set
15
Study
5
System
9
Technology
6
Therapeutics
66
Therapy
23
Travel
5
Treatment
38
Trial
19
Update
5
Vaccine
19
Entities
3m company
10
Abbott laboratories
71
Abbvie inc.
90
Adaptimmune therapeutics plc
3
Albemarle corporation
3
Alphabet inc.
3
Amgen inc.
94
Aptargroup, inc.
4
Artelo biosciences, inc.
16
Astellas pharma inc
42
Astrazeneca plc
450
Avenue therapeutics, inc.
7
Aveo pharmaceuticals, inc.
4
Bausch health companies inc.
11
Baxter international inc.
26
Becton, dickinson and company
5
Biogen inc.
20
Biomarin pharmaceutical inc.
4
Biontech se
6
Boston scientific corporation
4
Bristol-myers squibb company
53
Checkpoint therapeutics, inc.
5
Csl ltd
14
Eli lilly and company
81
Endo international plc
9
Fibrogen, inc
3
Fortress biotech, inc.
29
Galapagos nv
8
Genprex, inc.
9
Gilead sciences, inc.
8
Glaxosmithkline plc
158
Hutchison china meditech limited
4
Incyte corporation
3
Ionis pharmaceuticals, inc.
4
Ironwood pharmaceuticals, inc.
3
Jazz pharmaceuticals plc
5
Johnson & johnson
88
Journey medical corp
6
Koninklijke philips n.v.
7
Mallinckrodt plc
4
Medtronic plc
12
Mitsubishi chemical holdings corp
5
Mustang bio, inc.
6
Novartis ag
172
Novo nordisk a/s
20
Orange
4
Perrigo company
4
Pfizer, inc.
35
Puma biotechnology inc
6
Q biomed inc.
4
Reckitt benckiser group plc
6
Regeneron pharmaceuticals, inc.
4
Sanofi
174
Takeda pharmaceutical company limited
27
Teva pharmaceutical industries limited
7
Teva pharmaceutical industries ltd
85
Thermo fisher scientific inc
17
Ucb s.a.
4
Vertex pharmaceuticals incorporated
4
Viatris inc.
31
Symbols
AAPL
1198
ABB
1433
ABBV
1029
ABLZF
1172
ABT
1796
ACN
602
AMGN
744
ARVL
4306
AVGO
597
AZN
667
BDX
796
BMY
662
BNPQF
1767
BNPQY
1767
CSCO
900
DHR
786
ERIC
1614
F
643
FNCTF
7217
FRBA
600
GE
918
GLAXF
661
GOOG
1295
GOOGL
1294
GSK
887
HON
1791
HUBS
1400
IBM
655
INTC
955
IT
595
JNJ
4595
LLY
1710
LTUM
972
LYV
717
MDT
1286
MMM
938
MS
4291
MSFT
1203
MT
592
NOK
904
NOKBF
980
NVO
634
NVS
1244
NVSEF
1034
ORCL
1160
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1131
PPRUY
1132
SAP
1480
SAPGF
1234
SNOW
796
SNY
4550
SNYNF
3608
TEVJF
632
TMO
1627
VZ
1221
XYF
678
Exchanges
Amex
2
Nasdaq
450
Nyse
340
Crawled Date
2024 - 03 - 11
5
2024 - 01 - 30
3
2024 - 01 - 24
3
2024 - 01 - 12
4
2023 - 12 - 12
3
2023 - 08 - 25
3
2023 - 06 - 28
3
2023 - 04 - 13
4
2023 - 02 - 02
3
2022 - 12 - 30
2
2022 - 12 - 15
2
2022 - 12 - 06
5
2022 - 11 - 29
2
2022 - 11 - 28
2
2022 - 11 - 08
2
2022 - 11 - 03
2
2022 - 11 - 02
2
2022 - 10 - 19
2
2022 - 10 - 14
2
2022 - 10 - 06
2
2022 - 09 - 28
2
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 09 - 16
2
2022 - 09 - 13
2
2022 - 08 - 22
2
2022 - 08 - 08
2
2022 - 08 - 05
2
2022 - 08 - 02
3
2022 - 07 - 26
2
2022 - 07 - 19
2
2022 - 07 - 13
2
2022 - 06 - 27
3
2022 - 06 - 24
2
2022 - 06 - 17
3
2022 - 06 - 03
3
2022 - 05 - 25
2
2022 - 05 - 23
2
2022 - 05 - 17
3
2022 - 05 - 16
4
2022 - 04 - 26
3
2022 - 04 - 21
2
2022 - 03 - 28
2
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 09
2
2022 - 03 - 03
3
2022 - 03 - 02
3
2022 - 03 - 01
2
2022 - 02 - 23
2
2022 - 02 - 22
2
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2022 - 01 - 21
2
2021 - 11 - 24
3
2021 - 11 - 03
2
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 04
2
Crawled Time
00:00
17
00:20
4
01:00
16
02:00
12
03:00
12
04:00
10
04:20
9
05:00
8
06:00
8
07:00
12
08:00
5
09:00
15
10:00
13
11:00
18
12:00
23
12:20
10
12:30
4
13:00
16
13:15
1
13:20
8
13:30
7
14:00
21
14:15
1
14:20
5
14:30
5
15:00
17
15:20
9
15:30
7
16:00
23
16:20
2
17:00
19
18:00
18
19:00
24
20:00
15
21:00
12
22:00
18
23:00
26
Source
ir.chemocentryx.com
1
www.biospace.com
50
www.chi-med.com
1
www.globenewswire.com
42
www.prnewswire.com
356
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
AZNCF
save search
Alpha Glucosidase inhibitors market size to increase by USD 567.96 million by 2026; North America to account for 42% of market growth - Technavio
Published:
2023-02-17
(Crawled : 10:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
0.57%
|
O:
0.59%
H:
0.22%
C:
-1.69%
NVS
|
News
|
$97.295
2.29%
0.0%
3.7M
|
Health Technology
|
10.25%
|
O:
-0.24%
H:
1.61%
C:
1.52%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-1.09%
|
O:
1.22%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
3.21%
|
O:
0.43%
H:
1.47%
C:
1.07%
america
growth
market
Helocyte, Inc. Announces Positive Data from Stem Cell Transplant Donor Vaccination Trial to be Presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
Published:
2023-02-16
(Crawled : 14:00)
- globenewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-1.46%
|
O:
-2.87%
H:
0.88%
C:
0.88%
FBIO
|
$1.79
2.29%
2.23%
190K
|
Health Technology
|
135.69%
|
O:
0.81%
H:
5.54%
C:
3.66%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
0.63%
|
O:
-2.65%
H:
1.22%
C:
0.16%
cibmtr
trial
positive
therapy
Global Melanoma Therapeutics Market to Reach $9.5 Billion by 2030
Published:
2023-02-15
(Crawled : 16:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
1.08%
|
O:
0.66%
H:
1.9%
C:
1.9%
PFE
|
News
A
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-39.94%
|
O:
-0.69%
H:
0.44%
C:
-0.23%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-31.99%
|
O:
0.07%
H:
0.24%
C:
-1.15%
IOVA
M
|
$11.86
4.77%
4.55%
3.9M
|
Health Technology
|
54.22%
|
O:
-0.48%
H:
1.3%
C:
-0.34%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-0.3%
|
O:
-1.28%
H:
0.56%
C:
0.36%
melanoma
global
therapeutics
market
Regenerative Medicine Market to be Worth $180.87 Billion by 2030: Grand View Research, Inc.
Published:
2023-02-14
(Crawled : 10:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-0.39%
|
O:
0.43%
H:
1.52%
C:
-1.88%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
30.85%
|
O:
0.34%
H:
0.0%
C:
0.0%
USRM
|
$0.0001
1300.0%
290K
|
Professional, Scientific, and T...
|
-97.78%
|
O:
2.22%
H:
4.35%
C:
4.35%
PFE
|
News
A
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-40.3%
|
O:
0.23%
H:
0.25%
C:
-0.84%
NVS
|
News
|
$97.295
2.29%
0.0%
3.7M
|
Health Technology
|
8.32%
|
O:
0.27%
H:
0.42%
C:
-0.21%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
108.71%
|
O:
0.04%
H:
0.93%
C:
-0.85%
NUVA
|
$39.75
-2.24%
-2.29%
0
|
Health Technology
|
-10.15%
|
O:
-0.16%
H:
2.24%
C:
0.79%
MDXG
|
$6.505
2.28%
2.23%
750K
|
Health Technology
|
37.66%
|
O:
-1.3%
H:
2.85%
C:
2.19%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
0.6%
|
O:
0.3%
H:
0.94%
C:
0.6%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
11.59%
|
O:
-0.39%
H:
0.12%
C:
-0.69%
market
Non-invasive Glucose Monitoring Devices Market to Grow by USD 22.49 Mn, Abbott Laboratories and BlueSemi Among Key Vendors - Technavio
Published:
2023-02-13
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-0.39%
|
O:
0.43%
H:
1.52%
C:
-1.88%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
30.85%
|
O:
0.34%
H:
0.0%
C:
0.0%
MMAT
|
$2.95
9.67%
8.81%
180K
|
Mining, Quarrying, and Oil and ...
|
262.19%
|
O:
0.98%
H:
2.0%
C:
-1.93%
NVS
|
News
|
$97.295
2.29%
0.0%
3.7M
|
Health Technology
|
8.32%
|
O:
0.27%
H:
0.42%
C:
-0.21%
MDT
|
$81.29
0.89%
0.0%
5.2M
|
Health Technology
|
-4.53%
|
O:
-0.34%
H:
0.48%
C:
-0.83%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
-0.25%
|
O:
0.0%
H:
0.54%
C:
-1.46%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
9.21%
|
O:
0.12%
H:
0.05%
C:
-0.86%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-1.34%
|
O:
-0.3%
H:
0.14%
C:
-0.86%
NMRD
|
$0.072
-28.78%
43K
|
Health Technology
|
-94.57%
|
O:
3.88%
H:
0.0%
C:
-5.97%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
0.6%
|
O:
0.3%
H:
0.94%
C:
0.6%
market
HDAC (Histone Deacetylase) Inhibitors Market to Grow by USD 172.61 Mn, Curis Inc. and Bristol Myers Squibb Co. Among Key Vendors - Technavio
Published:
2023-02-13
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-0.39%
|
O:
0.43%
H:
1.52%
C:
-1.88%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
30.85%
|
O:
0.34%
H:
0.0%
C:
0.0%
VIRX
|
$0.831
-5.57%
-5.9%
84K
|
Manufacturing
|
-54.29%
|
O:
1.3%
H:
7.18%
C:
2.56%
NVS
|
News
|
$97.295
2.29%
0.0%
3.7M
|
Health Technology
|
8.32%
|
O:
0.27%
H:
0.42%
C:
-0.21%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
0.6%
|
O:
0.3%
H:
0.94%
C:
0.6%
market
Anesthesia Drugs Market to Grow by USD 1.38 Bn, AbbVie Inc. and Baxter International Inc. Among Key Vendors - Technavio
Published:
2023-02-13
(Crawled : 01:00)
- prnewswire.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
-95.56%
|
O:
-1.11%
H:
7.98%
C:
2.02%
NVS
|
News
|
$97.295
2.29%
0.0%
3.7M
|
Health Technology
|
9.59%
|
O:
0.39%
H:
0.81%
C:
0.77%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
-1.34%
|
O:
0.12%
H:
0.0%
C:
-1.22%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
10.42%
|
O:
-0.02%
H:
1.16%
C:
1.12%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
1.81%
|
O:
-0.51%
H:
1.81%
C:
1.72%
abbvie
international
market
Global Immunotherapy Drugs Market Report to 2028 - Players Include F. Hoffmann-La Roche, GSK, Merck & Co, Pfizer and Sanofi
Published:
2023-02-11
(Crawled : 16:20)
- prnewswire.com
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
global
immunotherapy
report
sanofi
market
Fortress Biotech Announces Closing of $13.9 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published:
2023-02-10
(Crawled : 18:00)
- globenewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
1.82%
|
O:
1.67%
H:
0.55%
C:
0.55%
FBIO
|
$1.79
2.29%
2.23%
190K
|
Health Technology
|
130.08%
|
O:
-2.71%
H:
6.03%
C:
2.7%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
4.02%
|
O:
1.77%
H:
0.56%
C:
0.39%
offering
nasdaq
biotech
direct
Liver cancer drugs market size to grow by USD 5.29 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
Published:
2023-02-09
(Crawled : 03:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
8.37%
|
O:
6.07%
H:
1.75%
C:
0.35%
QBIO
|
$0.0002
100.0%
1.1K
|
Professional, Scientific, and T...
|
-99.98%
|
O:
-4.0%
H:
4.17%
C:
4.17%
NVS
|
News
|
$97.295
2.29%
0.0%
3.7M
|
Health Technology
|
9.07%
|
O:
0.87%
H:
0.17%
C:
-1.53%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
8.97%
|
O:
6.13%
H:
0.42%
C:
-1.3%
liver
cancer
market
Global Venom Based Drugs Market Research Report 2022-2023 & 2027: Increasing Use of Venom in Numerous Diseases & Technological Advancements and Rise in R&D Activities Bodes Well
Published:
2023-02-09
(Crawled : 01:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
8.37%
|
O:
6.07%
H:
1.75%
C:
0.35%
NVS
|
News
|
$97.295
2.29%
0.0%
3.7M
|
Health Technology
|
9.07%
|
O:
0.87%
H:
0.17%
C:
-1.53%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-33.28%
|
O:
-0.22%
H:
0.48%
C:
-2.72%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
8.97%
|
O:
6.13%
H:
0.42%
C:
-1.3%
research
global
report
market
Fortress Biotech Announces Pricing of $13.9 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published:
2023-02-08
(Crawled : 15:20)
- biospace.com/
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
7.79%
|
O:
-0.05%
H:
0.0%
C:
-0.49%
FBIO
|
$1.79
2.29%
2.23%
190K
|
Health Technology
|
109.58%
|
O:
-14.99%
H:
12.71%
C:
6.31%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
9.08%
|
O:
1.52%
H:
0.02%
C:
-1.39%
offering
nasdaq
biotech
direct
Pulmonary Arterial Hypertension (PAH) Drugs Global Market 2022: Sector to Reach $9.4 Billion by 2027 at a CAGR of 5.29%
Published:
2023-02-03
(Crawled : 12:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
17.48%
|
O:
0.12%
H:
0.58%
C:
0.52%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
9.17%
|
O:
-0.63%
H:
2.15%
C:
1.68%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-9.92%
|
O:
0.3%
H:
0.19%
C:
-0.86%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
15.54%
|
O:
0.71%
H:
0.42%
C:
-1.55%
UTHR
|
$234.445
0.16%
0.16%
420K
|
Health Technology
|
-9.8%
|
O:
-0.1%
H:
1.37%
C:
-2.48%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
11.05%
|
O:
0.79%
H:
0.69%
C:
-0.33%
global
hypertension
market
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossExpects to Commence Phase 2a of CAReS During the First Quarter of 2023
Published:
2023-02-02
(Crawled : 15:20)
- biospace.com/
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
8.55%
|
O:
-2.3%
H:
2.11%
C:
1.78%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
10.34%
|
O:
-0.31%
H:
0.05%
C:
-0.33%
ARTL
|
News
|
$1.3004
1.87%
15K
|
Health Technology
|
-58.73%
|
O:
-1.27%
H:
1.67%
C:
-0.96%
art27
treatment
cares
trial
art27.13
phase 2b
TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
Published:
2023-02-02
(Crawled : 15:00)
- biospace.com/
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
8.55%
|
O:
-2.3%
H:
2.11%
C:
1.78%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
10.34%
|
O:
-0.31%
H:
0.05%
C:
-0.33%
tezspire
approved
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published:
2023-02-02
(Crawled : 14:20)
- globenewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
8.55%
|
O:
-2.3%
H:
2.11%
C:
1.78%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
10.34%
|
O:
-0.31%
H:
0.05%
C:
-0.33%
ARTL
|
News
|
$1.3004
1.87%
15K
|
Health Technology
|
-58.73%
|
O:
-1.27%
H:
1.67%
C:
-0.96%
art27
treatment
cares
trial
art27.13
phase 2b
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner
Published:
2023-01-31
(Crawled : 12:20)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
7.24%
|
O:
-1.05%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.95%
|
O:
-0.19%
H:
1.07%
C:
1.06%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
6.52%
|
O:
-1.22%
H:
0.52%
C:
0.51%
growth
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published:
2023-01-30
(Crawled : 17:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
6.86%
|
O:
1.09%
H:
2.18%
C:
-1.43%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-16.66%
|
O:
-0.19%
H:
0.13%
C:
-0.69%
PFE
|
News
A
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-40.03%
|
O:
0.0%
H:
0.79%
C:
-0.55%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-11.36%
|
O:
-0.18%
H:
0.36%
C:
-3.53%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-2.62%
|
O:
-0.13%
H:
0.78%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
7.02%
|
O:
1.3%
H:
0.06%
C:
-0.81%
global
report
gastrointestinal
therapeutics
market
GERD market size to increase by USD 908.49 million; North America to account for 38% of market growth - Technavio
Published:
2023-01-25
(Crawled : 03:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
19.06%
|
O:
1.47%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
7.13%
|
O:
3.2%
H:
0.64%
C:
-1.44%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
16.97%
|
O:
0.69%
H:
0.92%
C:
0.66%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-4.85%
|
O:
-2.25%
H:
2.04%
C:
0.91%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
5.81%
|
O:
-0.66%
H:
1.62%
C:
1.2%
america
growth
market
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
Published:
2023-01-23
(Crawled : 13:00)
- biospace.com/
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
1.66%
|
O:
0.18%
H:
0.85%
C:
-2.21%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
1.42%
|
O:
-0.64%
H:
0.57%
C:
-1.6%
acquire
← Previous
1
2
…
7
8
9
10
11
12
13
14
15
…
22
23
Next →
Gainers vs Losers
79%
21%
Top 10 Gainers
MTTR
|
News
M
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
870K
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.